Ketamine, a dissociative anesthetic commonly used by US physicians, has recently been

shown to be a powerful anti-depressant and is also capable of eliciting transpersonal experiences

that can be transformative. Although currently approved in the US only for use as an

anesthetic, physicians there can legally prescribe it off-label to treat various psychological/

psychiatric problems and it has been used for these non-anesthetic purposes in Argentina,

Iran, Mexico, Russia, and the UK, as well as in the US. The literature on using ketamine

psychotherapeutically is reviewed and two case studies using ketamine-enhanced psychotherapy

(KEP) for treating death anxiety in terminally-ill people are reported. The potential

importance of beginning formal research on using KEP during end-of-life for those suffering

death anxiety is emphasized.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.